PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
NIH seeks US small businesses for STTR grants; no clinical trials allowed; see specific research topics for application.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: September 5, 2024 | January 5, 2025 | April 5, 2025 | September 5, 2025
Funding Amounts: Phase I: up to $306,872 (1 year) | Phase II: up to $2,045,816 (2 years); higher budgets possible for select topics
Summary: Supports US small businesses collaborating with research institutions to develop and commercialize innovative health-related technologies; clinical trials are not allowed.
Key Information: Only US small businesses are eligible; foreign organizations cannot apply; see topic-specific budget limits and requirements.
Description
This opportunity, issued by the National Institutes of Health (NIH), invites eligible US small businesses to apply for Small Business Technology Transfer (STTR) grants (R41/R42) to support research and development of innovative technologies with strong commercialization potential in health, medicine, and related fields. The program requires a formal collaboration between a small business and a US research institution. Clinical trials are not permitted under this solicitation.
The STTR program aims to foster technology transfer through cooperative R&D between small businesses and research institutions, accelerating the translation of scientific discoveries into products and services that improve public health. Projects must align with the research missions of participating NIH Institutes and Centers.
